Acute Myeloblastic Leukemia without Maturation

Symptoms, Doctors, Treatments, Research & More

Condition 101

What are the alternative names for Acute Myeloblastic Leukemia without Maturation?

  • Acute myeloblastic leukemia type 1
  • Acute myeloblastic leukemia M1
  • AML M1

Latest Research

Latest Advance
  • Condition: Clostridioides Difficile Infections (CDI) in Patients with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Chemotherapy
  • Journal: Annals of hematology
  • Treatment Used: Carbapenems and Glycopeptides
  • Number of Patients: 415
  • Published —
This study analyzed the incidence of Clostridioides difficile infections (CDI) in patients with acute myeloid leukemia (AML) undergoing intensive induction chemotherapy.
Latest Advance
  • Condition: Acute Myeloid Leukemia
  • Journal: The Lancet. Haematology
  • Treatment Used: 10-day Decitabine with Venetoclax
  • Number of Patients: 168
  • Published —
The study researched the safety and effectiveness of 10-day decitabine with venetoclax for acute myeloid leukemia.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 40
  • Start Date: January 1, 2021
Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
Clinical Trial
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 62
  • Start Date: December 31, 2020
Phase Ib Study of Fludarabine, Cytarabine (Ara-C) and Pegylated Erwinase (Pegcrisantaspase) in Patients With Relapsed or Refractory Leukemia